Cyprus vs Latvia: Breast cancer screening coverage in Europe
Cyprus
29.3%
in 2022
Latvia
30.2%
in 2022
Cyprus rank
23rd
Latvia rank
21st
Breast cancer screening coverage in Europe over time
- Cyprus
- Latvia
How they compare
Latvia currently reports 30.2% against 29.3% in Cyprus, a difference of 0.9%.
The two have swapped places 2 times across 12 shared years of data; in 2011 it was Latvia ahead.
Cyprus ranks 23rd and Latvia ranks 21st of 26 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 33.1% | 36.0% | 2.9% | Latvia |
| 2020s | 27.0% | 30.3% | 3.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Cyprus or Latvia?
- Latvia, at 30.2% against 29.3% in Cyprus as of 2022.
- What is the difference in breast cancer screening coverage in europe between Cyprus and Latvia?
- 0.9%, with Latvia ahead.
- How many years of comparable data are there for Cyprus and Latvia?
- 12 years are reported by both, from 2011 to 2022.
- How do Cyprus and Latvia rank globally for breast cancer screening coverage in europe?
- Cyprus ranks 23rd and Latvia ranks 21st of 26 countries.
- Where does this data come from?
- Eurostat (2024) β processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.